OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?
Hatice Odabaş, Akif Doğan, Melike Özçelik, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 557-557
Open Access | Times Cited: 7
Hatice Odabaş, Akif Doğan, Melike Özçelik, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 557-557
Open Access | Times Cited: 7
Showing 7 citing articles:
Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis
Francisco Cézar Aquino de Moraes, Caroline R. M. Pereira, Vitor Kendi Tsuchiya Sano, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Francisco Cézar Aquino de Moraes, Caroline R. M. Pereira, Vitor Kendi Tsuchiya Sano, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Efficacy of cyclin-dependent kinase inhibitors with concurrent proton pump inhibitors in patients with breast cancer: a systematic review and meta-analysis
Zijie Guo, Ziyu Zhu, Mingpeng Luo, et al.
The Oncologist (2025) Vol. 30, Iss. 2
Open Access
Zijie Guo, Ziyu Zhu, Mingpeng Luo, et al.
The Oncologist (2025) Vol. 30, Iss. 2
Open Access
Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer
Kaori Takahashi, Ryuji Uozumi, Toru Mukohara, et al.
The Oncologist (2024) Vol. 29, Iss. 6, pp. e741-e749
Open Access | Times Cited: 4
Kaori Takahashi, Ryuji Uozumi, Toru Mukohara, et al.
The Oncologist (2024) Vol. 29, Iss. 6, pp. e741-e749
Open Access | Times Cited: 4
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
Elisa Agostinetto, Georg Pfeiler, Dominik Hlauschek, et al.
ESMO Open (2025) Vol. 10, Iss. 1, pp. 104096-104096
Open Access
Elisa Agostinetto, Georg Pfeiler, Dominik Hlauschek, et al.
ESMO Open (2025) Vol. 10, Iss. 1, pp. 104096-104096
Open Access
The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis
Yu-Cheng Chang, Junmin Song, Yu‐Tzu Chang, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5133-5133
Open Access | Times Cited: 3
Yu-Cheng Chang, Junmin Song, Yu‐Tzu Chang, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5133-5133
Open Access | Times Cited: 3
Palbociclib in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer: A Systematic Scoping Review of Real-World Evidence from Countries Outside of Western Regions that Are Underrepresented in Clinical Trials
Amit Rauthan, Ankita Jain, Manmohan Singh, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 3, pp. 395-418
Open Access
Amit Rauthan, Ankita Jain, Manmohan Singh, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 3, pp. 395-418
Open Access
Clinical implications of the Drug-Drug interaction in cancer patients treated with innovative oncological treatments
Fiorenza Santamaria, Michela Roberto, Dorelsa Buccilli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104405-104405
Closed Access
Fiorenza Santamaria, Michela Roberto, Dorelsa Buccilli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104405-104405
Closed Access
